FAQ

Enoxacin:Susc:Pt:Isolate:OrdQn:MIC

Known as: Enoxacin Islt MIC, Enoxacine:Gevoeligheid:Moment:Isolaat:OrdinaalKwantitatief:Mininmaal inhiberende concentratie, Enoxacina:Susc:Pt:Isolato:OrdQn:MIC 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2007
02419852007

Related topics

Related topics

3 relations
EnoxacinIsolate - microorganismMinimum Inhibitory Concentration measurement

Related mentions per year

Related mentions per year

1938-2018
19401960198020002020
Enoxacin:Susc:Pt:Isolate:OrdQn:MIC
Minimum Inhibitory Concentration measurement
Isolate - microorganism
Enoxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Enoxacin-Tb3+ complex as an environmentally friendly fluorescence probe for DNA and its application.
The fluorescence intensity of the enoxacin (ENX)-Tb(3+) complex enhanced by DNA was studied. On the basis of this study, an… (More)
Is this relevant?
2005
2005
Enoxacin-Konzentrationen im Serum und in der Dickdarmwand während eines kolorektalen Eingriffs
Ein zur Infektionsprophylaxe in der Dickdarmchirurgie verwendetes Antibiotikum muß während der Operation ausreichend hohe… (More)
Is this relevant?
2005
2005
Enoxacin und Theophyllin
  • Firma Parke-Davis, Enoxacin und Theophyllin
  • Infection
  • 2005
Bei zwei Studien an Patienten mit chronischen obstruktiven Lungenerkrankungen (1, 2) zeigte sich, dab bei gleichzeitiger… (More)
Is this relevant?
2005
2005
Empfindlichkeit klinisch wichtiger Bacteroides spp. gegenüber den Kombinationen Enoxacin-Metronidazol und Enoxacin-Clindamycin
Die minimalen Hemmkonzentrationen (MHK) von Enoxacin, Clindamycin und Metronidazol wurden bei klinischen Isolaten… (More)
Is this relevant?
1989
1989
Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole
In infections of polymicrobial etiology, it seems mandatory to combine an antibiotic with marginal activity against anaerobes… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Review
1988
Review
1988
Pharmacokinetics of ciprofloxacin
The fluorination of piperazinyl substituted quinolones has led to an interesting development of a series of new broad spectrum… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1986
1986
Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections
The efficacy and tolerance of enoxacin were tested in 65 patients treated for ear, nose and throat infections with doses of 400… (More)
Is this relevant?
1986
1986
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norfloxacin (400 mg p.o… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
1986
1986
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice
The chemotherapeutic activity of ofloxacin (HOE 280), a new pyridone-carboxylic acid derivative, was compared with that of other… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
1985
1985
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections
Minimal inhibitory concentrations (MIC) of enoxacin, nalidixic acid, pipemidic acid, norfloxacin, ciprofloxacin, ofloxacin and… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?